(RTTNews) MaxCyte, Inc. (MXCT) has entered into a definitive agreement to acquire Akron BioProducts LLC from affiliates of Arcline Investment Management for total consideration of $151.8 million. At...
Source
NASDAQ US Markets
-
Nov 10, 2026 11:33:26